Invega Sustenna

Invega Sustenna Contraindications



Johnson & Johnson


Full Prescribing Info
Known hypersensitivity to paliperidone or to any of the components of Invega Sustenna. Since paliperidone is an active metabolite of risperidone, Invega Sustenna is contraindicated in patients with a known hypersensitivity to risperidone.
Use in lactation: In animal studies with paliperidone and in human studies with risperidone, paliperidone was excreted in the milk. Therefore, women receiving Invega Sustenna should not breastfeed infants.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in